Page 25 - Product Testing News Today

Press release content from Business Wire. The AP news staff was not involved in its creation. Completion of the Third Clinical Trial - an Important Achievement for Medicortex Finland April 15, 2021 GMT TURKU, Finland--(BUSINESS WIRE)--Apr 15, 2021-- Medicortex Finland Oy, a biotechnology company developing a breakthrough biomarker-based diagnostic kit for brain injury detection, completed collection of body fluid samples in its third large clinical study. Children and adolescents were recruited...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. CytoDyn Executes Exclusive Supply and Distribution Agreement with Chiral Pharma Corporation to ... CytoDyn Inc.April 15, 2021 GMT Under Compassionate Special Permit (CSP) in Philippines, CytoDyn is well positioned to generate significant revenues VANCOUVER, Washington., April 15, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology comp...

Press release content from PR Newswire. The AP news staff was not involved in its creation. airKAVE Portable Air Purifier Now Approved To Combat COVID-19 April 15, 2021 GMT AIRKAVE PORTABLE AIR PURIFIER NOW APPROVED TO COMBAT COVID-19 LOS ANGELES, April 15, 2021 /PRNewswire/ -- airKAVE, the world’s most advanced air purification technology, announced today that the airKAVE Portable passed the Characterization of Model AH01 Air Purification Device in Deactivation of Aerosolized SARS-COV-2 test...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Affimed Reports 2020 Financial Results and Highlights Recent Operational Progress Affimed N.V.April 15, 2021 GMT AFM13 monotherapy: Reported positive data from the preplanned interim analysis for the registration-directed trial in PTCL AFM13 combination with NK cells: Announced 100% objective response rate in four response evaluable patients, including 2 complete responses AFM24 monotherapy: AFM24 (ph...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Reata Announces the Appointments of Christy J. Oliger and Shamim Ruff to Its Board of Directors Reata Pharmaceuticals, Inc.April 15, 2021 GMT PLANO, Texas, April 15, 2021 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced the appointments of Christy J. Oliger and Shamim Ruff to its Bo...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Claritas Announces Letter of Intent to Acquire Exclusive Worldwide Rights to Develop R-107 for PAH Claritas Pharmaceuticals, Inc.April 14, 2021 GMT SAN FRANCISCO and TORONTO, April 14, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the “Company” or “Claritas”) today announced that it has entered into a binding Letter of Intent (the “LOI”) with S...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Oncurious NV Reports Encouraging Data from Phase 1 Dose Escalation Study of TB-403 in ... Oxurion NVApril 12, 2021 GMT Leuven, Belgium, Boston, MA, US, 12 April 2021 – 7.30 AM CET – ONCURIOUS NV, a Belgium-based biotech company focused on developing innovative oncology treatments, today announces that encouraging data from a Phase 1 dose escalation study of TB-403 in pediatric subjects with relap...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Valneva Completes Recruitment for Pivotal Phase 3 Trial of Chikungunya Vaccine Candidate and ... VALNEVAApril 12, 2021 GMT Saint-Herblain (France), April 12, 2021 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, today announced that it h...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ORIC Pharmaceuticals Presents Posters on Four Programs at the 2021 American Association for ... ORIC PharmaceuticalsApril 12, 2021 GMT SOUTH SAN FRANCISCO and SAN DIEGO, April 12, 2021 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of resistance in cancer, presented four preclinical poster presen...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Medigus: Polyrizon Commenced a Pre-Clinical Study Testing Several Formulations of its Bio-Gel ... Medigus LtdApril 12, 2021 GMT OMER, Israel, April 12, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced that Polyrizon Ltd. (which Medigus owns 33.24% of its share capital), a private compa...